Interim results from GSK’s Phase III trial for Jemperli could signal a new stand...
A £277 million grant is being given to four life sciences companies to boost man...
The initiation of a Phase I clinical study for orally administered VK2735 comes ...
The erythromelalgia trial is on track to start next quarter and will study sever...
The new collaboration will combine Regeneron’s VelociSuite technologies and Sono...
The collaboration aims to discover and develop new medicines using Evotec’s moda...
With reproducible and predictable results, deterministic test methods represent ...
Republicans interrogated HHS Secretary Xavier Becerra about issues like gender-a...
Experts who advise the WHO suggested that countries no longer need to consider o...
Oscar Health has tapped former Aetna CEO Mark Bertolini to be its new chief exec...
Congressional Republicans are scrambling to bar use of a quality-of-life metric,...
Intra-Cellular Therapies, maker of an approved treatment for schizophrenia and b...
Viking Therapeutics, a small biotechnology company, said its experimental medici...
All the evidence shows we don’t need to choose between stopping the current pand...
As AI tools for medical note-taking gain traction, patients, hospitals, and deve...
“The average person would assume that a higher dose is stronger and perhaps can ...
